168 related articles for article (PubMed ID: 22407918)
41. Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines.
Yamaguchi S; Tatsumi T; Takehara T; Sakamori R; Uemura A; Mizushima T; Ohkawa K; Storkus WJ; Hayashi N
Cancer; 2007 Oct; 110(7):1469-77. PubMed ID: 17685394
[TBL] [Abstract][Full Text] [Related]
42. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
[TBL] [Abstract][Full Text] [Related]
43. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
44. Induction of specific human cytotoxic T cells using dendritic cells transduced with an adenovector encoding rat epidermal growth factor receptor 2.
Suresh K; Scheid E; Klotz L; Venkateswaran V; Gauldie J; Foley R
Int J Oncol; 2011 Oct; 39(4):907-13. PubMed ID: 21769423
[TBL] [Abstract][Full Text] [Related]
45. Invariant natural killer T cells are natural regulators of murine spondylarthritis.
Jacques P; Venken K; Van Beneden K; Hammad H; Seeuws S; Drennan MB; Deforce D; Verbruggen G; Apostolaki M; Kollias G; Lambrecht BN; De Vos M; Elewaut D
Arthritis Rheum; 2010 Apr; 62(4):988-99. PubMed ID: 20131252
[TBL] [Abstract][Full Text] [Related]
46. CD1d-dependent, iNKT-cell cytotoxicity against keratinocytes in allergic contact dermatitis.
Balato A; Zhao Y; Harberts E; Groleau P; Liu J; Fishelevich R; Gaspari AA
Exp Dermatol; 2012 Dec; 21(12):915-20. PubMed ID: 23171451
[TBL] [Abstract][Full Text] [Related]
47. Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation.
Joshi SK; Lang GA; Devera TS; Johnson AM; Kovats S; Lang ML
J Leukoc Biol; 2012 May; 91(5):783-90. PubMed ID: 22331103
[TBL] [Abstract][Full Text] [Related]
48. Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.
Escribà-Garcia L; Alvarez-Fernández C; Tellez-Gabriel M; Sierra J; Briones J
J Transl Med; 2017 May; 15(1):115. PubMed ID: 28549432
[TBL] [Abstract][Full Text] [Related]
49. Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells.
Schneiders FL; Huijts CM; Mantici A; Menks MA; Scotet E; Veerhuis R; Verheul HM; de Gruijl TD; van der Vliet HJ
Clin Immunol; 2015 May; 158(1):92-9. PubMed ID: 25796193
[TBL] [Abstract][Full Text] [Related]
50. Invariant NKT cells induce plasmacytoid dendritic cell (DC) cross-talk with conventional DCs for efficient memory CD8+ T cell induction.
Shimizu K; Asakura M; Shinga J; Sato Y; Kitahara S; Hoshino K; Kaisho T; Schoenberger SP; Ezaki T; Fujii S
J Immunol; 2013 Jun; 190(11):5609-19. PubMed ID: 23630347
[TBL] [Abstract][Full Text] [Related]
51. Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.
Weinkove R; Brooks CR; Carter JM; Hermans IF; Ronchese F
Haematologica; 2013 Mar; 98(3):376-84. PubMed ID: 23065503
[TBL] [Abstract][Full Text] [Related]
52. Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141
Huang J; Zhou J; Ghinnagow R; Seki T; Iketani S; Soulard D; Paczkowski P; Tsuji Y; MacKay S; Cruz LJ; Trottein F; Tsuji M
Front Immunol; 2020; 11():2043. PubMed ID: 32973811
[TBL] [Abstract][Full Text] [Related]
53. Self-glycerophospholipids activate murine phospholipid-reactive T cells and inhibit iNKT cell activation by competing with ligands for CD1d loading.
Halder RC; Tran C; Prasad P; Wang J; Nallapothula D; Ishikawa T; Wang M; Zajonc DM; Singh RR
Eur J Immunol; 2019 Feb; 49(2):242-254. PubMed ID: 30508304
[TBL] [Abstract][Full Text] [Related]
54. CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy.
Hara A; Koyama-Nasu R; Takami M; Toyoda T; Aoki T; Ihara F; Kobayashi M; Hirono S; Matsutani T; Nakayama T; Iwadate Y; Motohashi S
Cancer Immunol Immunother; 2021 May; 70(5):1239-1254. PubMed ID: 33128583
[TBL] [Abstract][Full Text] [Related]
55. Function and expression of CD1d and invariant natural killer T-cell receptor in the cotton rat (Sigmodon hispidus).
Fichtner AS; Paletta D; Starick L; Schumann RF; Niewiesk S; Herrmann T
Immunology; 2015 Dec; 146(4):618-29. PubMed ID: 26346465
[TBL] [Abstract][Full Text] [Related]
56. Human Invariant Natural Killer T Cells Respond to Antigen-Presenting Cells Exposed to Lipids from Olea europaea Pollen.
Abos Gracia B; López Relaño J; Revilla A; Castro L; Villalba M; Martín Adrados B; Regueiro JR; Fernández-Malavé E; Martínez Naves E; Gómez Del Moral M
Int Arch Allergy Immunol; 2017; 173(1):12-22. PubMed ID: 28486236
[TBL] [Abstract][Full Text] [Related]
57. [Cancer vaccine therapy using genetically modified induced pluripotent stem cell-derived dendritic cells expressing the TAA gene].
Iwamoto H; Ojima T; Nakamori M; Nakamura M; Hayata K; Katsuda M; Iida T; Miyazawa M; Iwahashi M; Yamaue H
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1575-7. PubMed ID: 24393853
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.
Moll M; Andersson SK; Smed-Sörensen A; Sandberg JK
Blood; 2010 Sep; 116(11):1876-84. PubMed ID: 20530791
[TBL] [Abstract][Full Text] [Related]
59. CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosis.
Schneiders FL; Prodöhl J; Ruben JM; O'Toole T; Scheper RJ; Bonneville M; Scotet E; Verheul HM; de Gruijl TD; van der Vliet HJ
Cancer Immunol Res; 2014 Aug; 2(8):732-40. PubMed ID: 24934445
[TBL] [Abstract][Full Text] [Related]
60. CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion.
Gillessen S; Naumov YN; Nieuwenhuis EE; Exley MA; Lee FS; Mach N; Luster AD; Blumberg RS; Taniguchi M; Balk SP; Strominger JL; Dranoff G; Wilson SB
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8874-9. PubMed ID: 12847287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
